Blackford and Annalise.ai announced a commercial partnership in late April. Annalise.ai’s CXR and CTB solutions, which offer the capability to detect up to 124 findings on chest radiographs and up to 130 findings on non-contrast head CTs, will be brought to healthcare providers in EMEA via the Blackford platform.
The partnership, one of the latest in a very long line for Blackford, raises questions around the sustainability of its strategy in the longer term, as well as the value of the deal for Annalise.ai.
Read the full insight with a Signify Premium Insights - Healthcare IT subscription